Literature DB >> 18343059

Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.

Carmelo Puglia1, Paolo Blasi, Luisa Rizza, Aurélie Schoubben, Francesco Bonina, Carlo Rossi, Maurizio Ricci.   

Abstract

Dermal therapy is still a challenge due to the difficulties in controlling the active pharmaceutical ingredient (API) fate within the skin. Recently, lipid nanoparticles have shown a great potential as vehicle for topical administration of active substances, principally owing to the possible targeting effect and controlled release in different skin strata. Ketoprofen and naproxen loaded lipid nanoparticles were prepared, using hot high pressure homogenization and ultrasonication techniques, and characterized by means of photo correlation spectroscopy and differential scanning calorimetry. Nanoparticle behavior on human skin was assessed, in vitro, to determine drug percutaneous absorption (Franz cell method) and, in vivo, to establish the active localization (tape-stripping technique) and the controlled release abilities (UVB-induced erythema model). Results demonstrated that the particles were able to reduce drug penetration increasing, simultaneously, the permeation and the accumulation in the horny layer. A prolonged anti-inflammatory effect was observed in the case of drug loaded nanoparticles with respect to the drug solution. Direct as well as indirect evidences corroborate the early reports on the usefulness of lipid nanoparticles as carriers for topical administration, stimulating new and deeper investigations in the field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343059     DOI: 10.1016/j.ijpharm.2008.01.045

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  28 in total

1.  Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac.

Authors:  Chien Ngoc Nguyen; Thi Thuy Trang Nguyen; Hanh Thuy Nguyen; Tuan Hiep Tran
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

2.  Polyamide nanocapsules and nano-emulsions containing Parsol® MCX and Parsol® 1789: in vitro release, ex vivo skin penetration and photo-stability studies.

Authors:  Ibrahim Hanno; Cecilia Anselmi; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2011-09-23       Impact factor: 4.200

Review 3.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

4.  Inflammation-Responsive Drug-Conjugated Dextran Nanoparticles Enhance Anti-Inflammatory Drug Efficacy.

Authors:  Sangeun Lee; Alexandra Stubelius; Naomi Hamelmann; Vincent Tran; Adah Almutairi
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-13       Impact factor: 9.229

5.  Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.

Authors:  Punit P Shah; Pinaki R Desai; Apurva R Patel; Mandip S Singh
Journal:  Biomaterials       Date:  2011-11-26       Impact factor: 12.479

6.  Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Authors:  Punit P Shah; Pinaki R Desai; Mandip Singh
Journal:  J Control Release       Date:  2011-11-21       Impact factor: 9.776

7.  Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.

Authors:  Ram R Patlolla; Mahavir Chougule; Apurva R Patel; Tanise Jackson; Prasad N V Tata; Mandip Singh
Journal:  J Control Release       Date:  2010-02-11       Impact factor: 9.776

8.  Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery.

Authors:  Yin-Ku Lin; Zih-Rou Huang; Rou-Zi Zhuo; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2010-03-09

9.  Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol.

Authors:  Nasrin Ghouchi Eskandar; Spomenka Simovic; Clive A Prestidge
Journal:  Pharm Res       Date:  2009-04-22       Impact factor: 4.200

10.  Opening up the optical imaging window using nano-luciferin.

Authors:  Apurva R Patel; Ed Lim; Kevin P Francis; Mandip Singh
Journal:  Pharm Res       Date:  2014-05-16       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.